ホーム › 頭頸部扁平上皮癌 › バージニア › Arlington
Arlington、VAにおける頭頸部扁平上皮癌の臨床試験
Arlingtonとその周辺地域（約30マイル以内）の拠点で、頭頸部扁平上皮癌に関する26件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
被験者募集中第1相
- Site 04, Fairfax · 11マイル先
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
被験者募集中第1相
- ALX Center 2, Fairfax · 11マイル先
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
被験者募集中第3相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
被験者募集中第1/2相
- Virginia Cancer Specialists, Fairfax · 11マイル先
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
被験者募集中第2相
- Inova Fairfax Hospital, Falls Church · 4マイル先
- Inova Schar Cancer Institute, Fairfax · 11マイル先
- Inova Fair Oaks Hospital, Fairfax · 11マイル先
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
被験者募集中第1相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
被験者募集中第1/2相
- NEXT Virginia, Fairfax · 11マイル先
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
被験者募集中第1/2相
- NEXT Oncology, Fairfax · 11マイル先
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
被験者募集中第2相
- Inova Schar Cancer Institute, Fairfax · 11マイル先
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Research Site, Fairfax · 11マイル先
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
被験者募集中第1相
- Normunity Investigational Site, Fairfax · 11マイル先
A Study of DM005 in Patients With Advanced Solid Tumors
被験者募集中第1/2相
- NEXT Oncology Virginia, Fairfax · 11マイル先
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
被験者募集中第1/2相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- USO-Virginia Cancer Specialists, PC, Fairfax · 11マイル先
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
被験者募集中第1相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
被験者募集中第1/2相
- NEXT Oncology Virginia, Fairfax · 11マイル先
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- NEXT, Fairfax · 11マイル先
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
被験者募集中第1相
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11マイル先
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
被験者募集中第1相
- NEXT Texas LLC - Virginia, Fairfax · 11マイル先
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
被験者募集中第1/2相
- NEXT Virginia, Fairfax · 11マイル先
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- NEXT Virginia, Fairfax · 11マイル先
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
被験者募集中第1相
- Dren Investigational Site, Fairfax · 11マイル先
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
被験者募集中第1相
- NEXT Oncology, Fairfax · 11マイル先
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
被験者募集中第1/2相
- Research Site 102, Fairfax · 11マイル先
- Research Site 112, Fairfax · 11マイル先
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Virginia Cancer Specialists, Fairfax · 11マイル先
他の都市における頭頸部扁平上皮癌の試験
- Houston, TX47件の研究
- Los Angeles, CA42件の研究
- Boston, MA40件の研究
- New York City, NY39件の研究
- Nashville, TN39件の研究
- St. Louis, MO28件の研究
- Philadelphia, PA26件の研究
- Chicago, IL26件の研究
- Atlanta, GA24件の研究
- San Antonio, TX22件の研究
- New Haven, CT22件の研究
- Pittsburgh, PA22件の研究
Arlingtonにおける他の研究
- 非小細胞肺癌104件の研究
- 転移性癌53件の研究
- 大腸癌52件の研究
- がん（全種類）48件の研究
- 乳がん47件の研究
- 卵巣がん46件の研究
- 肺がん41件の研究
- 子宮内膜がん39件の研究
- 膵臓がん33件の研究
- 小細胞肺がん23件の研究
- 胃癌20件の研究
- トリプルネガティブ乳がん20件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。